New research presented at #ESCCongress shows women without traditional risk factors but with high inflammation face higher lifetime heart risks. Recognizing these unique profiles is key to ensuring equitable patient outcomes. Read more: academic.oup.com/eur...#ESCCongress #WomensHealth #CardioSky

Our new review on the evidence for primary prevention aspirin in individuals with elevated Lp(a) is out now. #CardioSky @ucsdcardiology.bsky.social @aspcardio.bsky.social @familyheartfdn.bsky.social link.springer.com/epdf/10.1007...

At #ACC25, we explored how to build successful trials through partnerships & innovation. ✅ Unique trial design can = diverse enrollment ✅ Start small, publish, & grow ✅ Industry interest follows proven patient enrollment Thanks to Novo Nordisk & all who joined us! #CardioSky

Excited to hear updates on @janetweimd.bsky.social #NIH #R01 on myocardial steatosis in women with #CMD: defining the pathway to #HFpEF #HFpEFSummit

After 2 years of shortages, the compounding market for glucagon-like peptide 1 (GLP-1) medication has exploded to include telehealth companies and compounding pharmacies. This Medical News article discusses GLP-1 drugs. #MedSky

Excited to share our recently in press manuscript in #Hypertension (@ahajournals.bsky.social) as my first official post here! www.ahajournals.org/doi/10.1161/...

Anticoagulation & Antiplatelet Therapy for #AFib & Stable CAD: Meta-analysis of RCTs Will this finally change the practice? #CardioSky #MedSky www.jacc.org/doi/10.1016/... @jaccjournals.bsky.social @bbikdeli.bsky.social @hmkyale.bsky.social @csilvers.bsky.social @load-dependent.bsky.social

CMR & adverse clinical outcomes in peripartum cardiomyopathy #WhyCMR #PPCM #CardioObstetrics #CardioSky #MFM #OBGYN @agneskoczo.bsky.social @garimasharmamd.bsky.social @erinmichos.bsky.social @cardioobdoc.bsky.social @drmarthagulati.bsky.social www.sciencedirect.com/science/arti...

Really thought-provoking. Sensible arguments by John G. F. Cleland in JAMA cardiology question long-term aspirin in secondary prevention. jamanetwork.com/journals/jam....

#Aspirin Monotherapy vs No Antiplatelet Therapy in Stable Patients With Coronary Stents Undergoing Low-to-Intermediate Risk Noncardiac Surgery (ASSURE-DES) Article www.jacc.org/doi/10.1016/... Editorial www.jacc.org/doi/10.1016/... #CardioSky #JACC #MedSky @jaccjournals.bsky.social

Most viewed in the last 7 days from JAMA: Muvalaplin reduced lipoprotein(a) measured using intact lipoprotein(a) and apolipoprotein(a)-based assays and was well tolerated. https://ja.ma/4eHAXLq